Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 29

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 29
---
 column represent the grant date fair value of the stock options granted to our non-employee directors as of the grant date as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, not including any estimates of forfeitures. The assumptions used in calculating the grant date fair value of the stock options reported in the Option Awards column are set forth i n Note 9 to our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. Note that the amounts reported in this column reflect the accounting cost for these stock options, and do not correspond to the actual economic value that may be received by our non-employee directors from the options.

(2) As of December 31, 2024, Dr. Castelein held options to purchase 117,727 shares of Company common stock and 19,694 shares of common stock, respectively.

(3) As of December 31, 2024, Dr. Dalal held options to purchase 117,727 shares of Company common stock and 1,130 shares of common stock, respectively.

(4) As of December 31, 2024, Ms. Reeve held options to purchase 109,146 shares of Company common stock.

(5) As of December 31, 2024, Dr. Aghazadeh held options to purchase 110,209 shares of Company common stock.

(6) As of December 31, 2024, Dr. Hehenberger held options to purchase 110,209 shares of Company common stock.

(7) As of December 31, 2024, Mr. Maroun held options to purchase 133,999 shares of Company common stock.

(8) As of December 31, 2024, Dr. Hirmand held options to purchase 105,038 shares of Company common stock.

(9) As of December 31, 2024, Dr. Zhao held options to purchase 61,192 shares of Company common stock.

<div align='center'>17</div>

### EXECUTIVE COMPENSATION

### Processes and Procedures for Compensation Decisions
Our Compensation Committee is responsible for the compensation programs for our executive officers and reports to our Board on its discussions, decisions and other actions. Typically, our Chief Executive Officer makes recommendations to our Compensation Committee, often attends committee meetings and is involved in the determination of compensation for the respective executive officers who report to the Chief Executive Officer, except that our Chief Executive